section name header

Y-Site Injection Compatibility (1:1 Mixture)

Colistimethate sodium

(Mfr: XGN)(Conc: 4.5 mg/mLa)

QMark

Imipenem-cilastatin sodium-relebactam

(Mfr: ME)(Conc: 5 mg/mLm)

Remarks:

Visually compatible; pH increased by nearly 2 units within 2 hr

Ref:

3604